UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

Transplantation of Human Embryonic Stem Cell–Derived Cardiovascular Progenitors for Severe Ischemic Left Ventricular Dysfunction

Journal of the American College of Cardiology, 2018-01, Vol.71 (4), p.429-438

2018

Link zum Volltext

Verfügbarkeit prüfen

Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience

European heart journal, 2015-03, Vol.36 (12), p.743-750

2015

Link zum Volltext

Verfügbarkeit prüfen

Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report

European heart journal, 2015-08, Vol.36 (30), p.2011-2017

2015

Link zum Volltext

Verfügbarkeit prüfen

Summary of knowledge gaps related to quality and efficacy of current influenza vaccines

Vaccine, 2014-07, Vol.32 (35), p.4586-4591

2014

Link zum Volltext

Verfügbarkeit prüfen

Manufacturing, characterization and control of cell-based medicinal products: challenging paradigms toward commercial use

Regenerative medicine, 2015-01, Vol.10 (1), p.65-78

2015

Link zum Volltext

Verfügbarkeit prüfen

Scientific considerations for the regulatory evaluation of cell therapy products

Biologicals, 2017-11, Vol.50, p.20-26

2017

Link zum Volltext

Verfügbarkeit prüfen

Development of extracellular vesicle-based medicinal products: A position paper of the group “Extracellular Vesicle translatiOn to clinicaL perspectiVEs – EVOLVE France”

Advanced drug delivery reviews, 2021-12, Vol.179, p.114001-114001, Article 114001

2021

Link zum Volltext

Verfügbarkeit prüfen

Biosimilars and the European experience: implications for the United States

Health affairs (Millwood, Va.), 2013-10, Vol.32 (10), p.1803

2013

Link zum Volltext

Verfügbarkeit prüfen

Setting the stage for biosimilar monoclonal antibodies

Nature biotechnology, 2012-12, Vol.30 (12), p.1179-1185

2012

Link zum Volltext

Verfügbarkeit prüfen

A biologicals Renaissance man: John C. Petricciani

Biologicals, 2020-11, Vol.68, p.1-2

2020

Link zum Volltext

Verfügbarkeit prüfen

Overview of the Regulatory Oversight Implemented by the French Regulatory Authorities for the Clinical Investigation of Gene Therapy and Cell Therapy Products

Advances in experimental medicine and biology, 2015-01, Vol.871, p.73

2015

Link zum Volltext

Verfügbarkeit prüfen

Science réglementaire en santé publique : de quoi parle-t-on ?

Santé publique (Vandoeuvre-lès-Nancy, France), 2018-06, Vol.30 (2), p.187-196

2018

Link zum Volltext

Verfügbarkeit prüfen

In support of the European Union biosimilar framework

Nature biotechnology, 2012-08, Vol.30 (8), p.745-748

2012

Link zum Volltext

Verfügbarkeit prüfen

Report of the international conference on manufacturing and testing of pluripotent stem cells

Biologicals, 2018-11, Vol.56, p.67-83

2018

Link zum Volltext

Verfügbarkeit prüfen

Similar biological medicinal products containing recombinant human growth hormone: European regulation

Hormone research, 2008-01, Vol.69 (1), p.14-21

2008

Link zum Volltext

Verfügbarkeit prüfen

Guidelines for Translational Research in Heart Failure

Journal of cardiovascular translational research, 2015-02, Vol.8 (1), p.3-22

2015

Link zum Volltext

Verfügbarkeit prüfen

Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report: Figure 1

European heart journal, 2015-08, Vol.36 (30), p.2011-2017

2015

Link zum Volltext

Verfügbarkeit prüfen

Serotonin synthesis and its light–dark variation in the rat retina

Journal of neurochemistry, 2002-11, Vol.83 (4), p.863-869

2002

Link zum Volltext

Verfügbarkeit prüfen

Clinical development of gene therapy needs a tailored approach: a regulatory perspective from the European Union

Human gene therapy. Clinical development, 2014-03, Vol.25 (1), p.1

2014

Link zum Volltext

Verfügbarkeit prüfen

Introductory note to the three-part series of papers by B Sharma on: Immunogenicity of therapeutic proteins: How to assess and the role of pharmaceutical quality

Biotechnology advances, 2007-05, Vol.25 (3), p.307-309

Trouvin, Jean-Hugues

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(54)
magazinearticle
(1)

Sprache

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Transplantation of Human Embryonic Stem Cell–Derived Cardiovascular Progenitors for Severe Ischemic Left Ventricular Dysfunction

Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience

A Decision Support Tool Facilitating Medicine Design for Optimal Acceptability in The Older Population

Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report

Summary of knowledge gaps related to quality and efficacy of current influenza vaccines

Manufacturing, characterization and control of cell-based medicinal products: challenging paradigms toward commercial use

Scientific considerations for the regulatory evaluation of cell therapy products

Development of extracellular vesicle-based medicinal products: A position paper of the group “Extracellular Vesicle translatiOn to clinicaL perspectiVEs – EVOLVE France”

Biosimilars and the European experience: implications for the United States

Setting the stage for biosimilar monoclonal antibodies

A biologicals Renaissance man: John C. Petricciani

Report of the international conference on regulatory endeavors towards the sound development of human cell therapy products

Controlled Human Infection Studies: Proposals for guidance on how to design, develop and produce a challenge strain

Overview of the Regulatory Oversight Implemented by the French Regulatory Authorities for the Clinical Investigation of Gene Therapy and Cell Therapy Products

Acceptability of oral liquid pharmaceutical products in older adults: palatability and swallowability issues

Science réglementaire en santé publique : de quoi parle-t-on ?

In support of the European Union biosimilar framework

Report of the international conference on manufacturing and testing of pluripotent stem cells

Similar biological medicinal products containing recombinant human growth hormone: European regulation

Guidelines for Translational Research in Heart Failure

Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report: Figure 1

Serotonin synthesis and its light–dark variation in the rat retina

Clinical development of gene therapy needs a tailored approach: a regulatory perspective from the European Union

Introductory note to the three-part series of papers by B Sharma on: Immunogenicity of therapeutic proteins: How to assess and the role of pharmaceutical quality

Erratum to “Report of the international conference on regulatory endeavors towards the sound development of human cell therapy products” [Biologicals 43 (5) (2015) 283–297]

Suchergebnisse filtern